The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-9A MM: Biology

Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Yusuke Furukawa (Division of Stem Cell Regulation, Jichi Medical University, Japan)

【Ｅ】

[OS3-9A-4] HDAC and AKT inhibitors enhance anti-myeloma effects of daratumumab

Mitsuhito Hirano1, Yoichi Imai2, Wengchif Ung1, Kota Sato3, Muneyoshi Futami1,2, Arinobu Tojo1,2 (1.Division of Molecular Therapy, IMSUT, 2.Department of Hematology/Oncology, IMSUT hospital, 3.Department of Hematology Japanese Red Cross Medical Center)

Abstract password authentication.
Password is written on a program and abstract book.

Password